News about air

KUALA LUMPUR (June 21): Senior lawyer Rosli Dahlan (pictured) has lodged a police report denying a UK-based portal's claim about his purported relationship with the judiciary, especially Chief Justice Tun Tengku Maimun Tuan Mat.

KUALA LUMPUR (June 21): Malaysia Airports Holdings Bhd (MAHB) has submitted a comprehensive strategic long-term development plan for the Sultan Abdul Aziz Shah Airport in Subang, Selangor to the government.

KUALA LUMPUR (June 20): Mohd Azharuddin Mat Sah (pictured), who is currently the chief transformation officer of Malaysia Airlines Bhd, could be appointed chief executive officer (CEO) of Prasarana Malaysia Bhd, sources said on condition of anonymity.

KUALA LUMPUR (June 13): A total of 133,804 Covid-19 vaccine doses were administered throughout the nation yesterday (Saturday, June 12), bringing the total doses administered to 4.

In April 2021, the ASHRAE Epidemic Task Force replaced the statement made 12 months earlier that said airborne transmission was “sufficiently likely” with an unequivocal revision: “Airborne transmission of SARS-CoV-2 is significant and should be controlled.

PETALING JAYA (June 10): Panasonic Solar Energy Malaysia’s solar cell and panel production plant in Kulim Hi-Tech Park (KHPT) is now up for sale as Panasonic Group has ceased solar production operations in Malaysia, said Knight Frank Malaysia.

KUALA LUMPUR (June 10): Selangor will receive 25% of all Covid-19 vaccine procurements, a Federal Minister said yesterday in response to the Selangor Sultan's remark that the State had only received about 600,000 vaccines so far.

KUALA LUMPUR (June 4): Malaysia is looking at providing incentives to shore up registration for Covid-19 vaccination, which remains near 50% of the adult population.

KUALA LUMPUR (May 28): Malaysia, which is currently ramping up its vaccination efforts to flatten the Covid-19 infection curve, is expecting nearly 16 million more doses of vaccines in the next two months.

KUALA LUMPUR (May 27): Due to the good response of the AstraZeneca vaccine, the next batch of it will no longer be available on a voluntary opt-in basis.